Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13-valent Pneumococcal Conjugate Vaccine in Healthy Children
NCT00761631Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2008
- Primary completion
- Aug 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started Nov 2008; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00761631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761631.